Tuberculosis
Investigators at the University of Dublin have made a significant breakthrough in the fight against Mycobacterium tuberculosis (Mtb), a type of bacteria that causes tuberculosis (TB). The research, recently published in the journal Scientific Reports, found that dexamethasone, a glucocorticoid hormone, has the potential to inhibit the growth of Mtb
Tuberculosis
Researchers have identified four distinct adherence patterns among patients treated for rifampicin- or multidrug-resistant tuberculosis (RR/MDR-TB), contradicting the traditional notion that sustained high adherence is necessary for treatment success. By analyzing data from the endTB observational study, a joint latent class mixed model was applied to classify adherence trajectories
Tuberculosis
Research published in Clinical Infectious Diseases has shed light on the risk of tuberculosis (TB) in patients treated with biologic therapies (BioT). A study conducted at the University of Barcelona, Spain, assessing the risk of TB in 1368 patients treated with BioT, found that TB infection was diagnosed in 327
Tuberculosis
Researchers from the Arabian Gulf University have published a study on the global research trends in BPaL and BPaLM regimens for drug-resistant tuberculosis, revealing the introduction of these regimens has revolutionized treatment, offering superior efficacy and tolerability. The study analyzed Scopus-indexed publications, identifying 1,081 authors and 120 studies meeting
Tuberculosis
A study published in BMC Microbiology has presented promising findings on a novel colorimetric test for diagnosing tuberculosis (TB) drug susceptibility in resource-constrained settings. The research, conducted by a team led by Binyam Mebrat from the Armauer Hansen Research Institute in Addis Ababa, Ethiopia, evaluated the performance of the phenotypic
Tuberculosis
Researchers at the Faculty of Medicine University of Indonesia have published a new study investigating the effectiveness of telemedicine-based directly observed therapy (DOTS) on treatment compliance in patients with tuberculosis. The study, which analyzed six systematic reviews, found that telemedicine-based DOTS yielded favorable effects in improving adherence, treatment completion, and
Tuberculosis
Researchers from Keele University have shed light on the critical issue of non-adherence to tuberculosis (TB) treatment among Afghan refugees and Pakistani nationals living in Pakistan. The study, published in the BMJ Open, identified several personal, sociocultural, and treatment-related barriers contributing to lower treatment adherence. These barriers include lack of
Tuberculosis
Tuberculosis (TB) is a significant global health issue, with the emergence of rifampicin-resistant TB (RR-TB) posing a substantial challenge to control efforts. Research from Zhejiang, China, has shed light on the characteristics of compensatory mutations in RR-TB strains and their association with transmission dynamics in coastal regions of Eastern China.
Tuberculosis
Researchers at the University of Liverpool School Tropical Medicine have presented data on a new treatment regimen for drug-resistant tuberculosis (TB). The study, which took place from January 2020 to December 2023, compared a standard injectable-containing regimen to an all-oral regimen for multidrug- and rifampicin-resistant TB (MDR/RR-TB). The results
Tuberculosis
Researchers at McGill University have made significant progress in understanding the diagnosis and treatment of spinal tuberculosis, also known as Pott's disease. According to recent studies, prompt diagnosis and treatment are crucial in preventing neurological and physical complications associated with this condition. Three Colombian cases of spinal tuberculosis
Tuberculosis
According to a new report published in the journal PLOS Neglected Tropical Diseases, researchers have identified key barriers to effective rabies control in rural Uganda. The study found that only an estimated 10% of dogs in Uganda are vaccinated against rabies, resulting in about 59,000 human deaths annually. The
Tuberculosis
A new study has reported a case of Achromobacter spp. infection in an immunocompetent woman with a history of pulmonary tuberculosis (PTB) and COVID-19. The study suggests that the high burden of TB and COVID-19 in Cameroon may lead to underreported pulmonary bacterial and fungal superinfections. Key Takeaways: * A 63-year-old
